Literature DB >> 10492768

Resistance to chloroquine and sulfadoxine-pyrimethamine in Plasmodium falciparum in Muheza district, Tanzania.

M Warsame1, V A Kilimali, W H Wernsdorfer, M Lebbad, A S Rutta, O Ericsson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10492768     DOI： 10.1016/s0035-9203(99)90034-2

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN： 0035-9203            Impact factor:   2.184


× No keyword cloud information.
  4 in total

Review 1.  History, dynamics, and public health importance of malaria parasite resistance.

Authors:  Ambrose O Talisuna; Peter Bloland; Umberto D'Alessandro
Journal:  Clin Microbiol Rev       Date:  2004-01       Impact factor: 26.132

2.  Using the social entrepreneurship approach to generate innovative and sustainable malaria diagnosis interventions in Tanzania: a case study.

Authors:  Lisa K Allen; Erin Hetherington; Mange Manyama; Jennifer M Hatfield; Guido van Marle
Journal:  Malar J       Date:  2010-02-03       Impact factor: 2.979

3.  Efficacy of chloroquine, amodiaquine and sulphadoxine-pyrimethamine for the treatment of uncomplicated falciparum malaria: revisiting molecular markers in an area of emerging AQ and SP resistance in Mali.

Authors:  Mamadou Tekete; Abdoulaye A Djimde; Abdoul H Beavogui; Hamma Maiga; Issaka Sagara; Bakary Fofana; Dinkorma Ouologuem; Souleymane Dama; Aminatou Kone; Demba Dembele; Mamadou Wele; Alassane Dicko; Ogobara K Doumbo
Journal:  Malar J       Date:  2009-02-26       Impact factor: 2.979

4.  High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581.

Authors:  Samwel Gesase; Roly D Gosling; Ramadhan Hashim; Rosalynn Ord; Inbarani Naidoo; Rashid Madebe; Jacklin F Mosha; Angel Joho; Victor Mandia; Hedwiga Mrema; Ephraim Mapunda; Zacharia Savael; Martha Lemnge; Frank W Mosha; Brian Greenwood; Cally Roper; Daniel Chandramohan
Journal:  PLoS One       Date:  2009-02-24       Impact factor: 3.240
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.